14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.94 $4.15 Friday, 3rd May 2024 CLRB stock ended at $3.42. This is 2.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.09% from a day low at $3.34 to a day high of $3.51.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Jun 18, 2020 $1.19 $1.25 $1.18 $1.20 429 890
Jun 17, 2020 $1.24 $1.25 $1.18 $1.19 525 728
Jun 16, 2020 $1.20 $1.23 $1.18 $1.23 503 434
Jun 15, 2020 $1.11 $1.20 $1.11 $1.18 697 451
Jun 12, 2020 $1.20 $1.21 $1.09 $1.17 788 945
Jun 11, 2020 $1.29 $1.30 $1.15 $1.16 1 229 408
Jun 10, 2020 $1.34 $1.34 $1.23 $1.29 1 207 233
Jun 09, 2020 $1.34 $1.38 $1.22 $1.24 2 428 295
Jun 08, 2020 $1.15 $1.19 $1.14 $1.18 1 364 549
Jun 05, 2020 $1.17 $1.20 $1.13 $1.14 1 897 911
Jun 04, 2020 $1.06 $1.15 $1.05 $1.14 3 748 546
Jun 03, 2020 $1.05 $1.08 $1.01 $1.03 11 447 598
Jun 02, 2020 $1.40 $1.43 $1.29 $1.32 715 819
Jun 01, 2020 $1.51 $1.59 $1.34 $1.43 359 877
May 29, 2020 $1.35 $1.55 $1.29 $1.51 774 570
May 28, 2020 $1.40 $1.41 $1.26 $1.35 764 031
May 27, 2020 $1.49 $1.49 $1.34 $1.41 615 013
May 26, 2020 $1.75 $1.79 $1.38 $1.51 5 192 036
May 22, 2020 $1.41 $1.45 $1.40 $1.41 25 530
May 21, 2020 $1.41 $1.45 $1.40 $1.40 45 521
May 20, 2020 $1.41 $1.49 $1.36 $1.44 61 341
May 19, 2020 $1.54 $1.54 $1.41 $1.47 83 503
May 18, 2020 $1.49 $1.54 $1.40 $1.51 43 587
May 15, 2020 $1.47 $1.48 $1.42 $1.44 18 599
May 14, 2020 $1.45 $1.53 $1.37 $1.40 118 114
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT